Your search returned 6 results.

Results
	1.	Quinazolines: combined type 3 and 4 phosphodiesterase inhibitors. [electronic resource] by Charpiot, B Brun, J Donze, I Naef, R Stefani, M Mueller, T Producer: 19990202 In: Bioorganic & medicinal chemistry letters vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Inhibitors of human immunodeficiency virus type 1 protease containing 2-aminobenzyl-substituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, activity, and oral bioavailability. [electronic resource] by Lehr, P Billich, A Charpiot, B Ettmayer, P Scholz, D Rosenwirth, B Gstach, H Producer: 19960718 In: Journal of medicinal chemistry vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterization. [electronic resource] by Billich, A Charpiot, B Fricker, G Gstach, H Lehr, P Peichl, P Scholz, D Rosenwirth, B Producer: 19950508 In: Antiviral research vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Inhibitors of HIV-1 proteinase containing 2-heterosubstituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, enzyme inhibition, and antiviral activity. [electronic resource] by Scholz, D Billich, A Charpiot, B Ettmayer, P Lehr, P Rosenwirth, B Schreiner, E Gstach, H Producer: 19941027 In: Journal of medicinal chemistry vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Disease activated drugs: a new concept for the treatment of asthma. [electronic resource] by Charpiot, B Bitsch, F Buchheit, K H Channez, P Mazzoni, L Mueller, T Vachier, I Naef, R Producer: 20010920 In: Bioorganic & medicinal chemistry vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. [electronic resource] by Rabin, L Hincenbergs, M Moreno, M B Warren, S Linquist, V Datema, R Charpiot, B Seifert, J Kaneshima, H McCune, J M Producer: 19970107 In: Antimicrobial agents and chemotherapy vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)